| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3229678
Max Phase: Preclinical
Molecular Formula: C15H22N4O7
Molecular Weight: 370.36
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)NCCCC(=O)Nc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C15H22N4O7/c1-8(21)16-4-2-3-12(23)17-9-6-19(15(25)18-14(9)24)13-5-10(22)11(7-20)26-13/h6,10-11,13,20,22H,2-5,7H2,1H3,(H,16,21)(H,17,23)(H,18,24,25)/t10-,11+,13+/m0/s1
Standard InChI Key: LUZCEUJLDXEEHV-DMDPSCGWSA-N
Associated Targets(non-human)
Thymidine kinase, cytosolic 80 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 370.36 | Molecular Weight (Monoisotopic): 370.1488 | AlogP: -1.97 | #Rotatable Bonds: 7 |
| Polar Surface Area: 162.75 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 5 |
| #RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 8.95 | CX Basic pKa: | CX LogP: -3.16 | CX LogD: -3.17 |
| Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.35 | Np Likeness Score: 0.06 |
References
| 1. Hampton A, Kappler F, Chawla RR.. (1979) Design of species- or isozyme-specific enzyme inhibitors. 1. Effect of thymidine substituents on affinity for the thymidine site of hamster cytoplasmic thymidine kinase., 22 (6): [PMID:458818] [10.1021/jm00192a005] |
Source
Source(1):